Concord Biotech Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
16148.56 Cr.
|
P/BV
|
10.15
|
Book Value (Rs.)
|
152.02
|
52 Week High/Low (Rs.)
|
2664/1327
|
FV/ML
|
1/1
|
P/E(X)
|
52.41
|
Bookclosure
|
29/06/2024
|
EPS (Rs.)
|
29.45
|
Div Yield (%)
|
0.57
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 10.00 |
| | | |
Net Profit/Loss Before Extraordinary Items And Tax | 412.57 | 322.01 | 237.52 |
| | | |
Net CashFlow From Operating Activities | 265.47 | 246.00 | 207.47 |
Net Cash Used In Investing Activities | -154.61 | -157.95 | -111.79 |
Net Cash Used From Financing Activities | -99.21 | -85.22 | -100.16 |
| | | |
Net Inc/Dec In Cash And Cash Equivalents | 11.64 | 2.83 | -4.48 |
Cash And Cash Equivalents Begin of Year | 3.50 | 0.67 | 5.14 |
Cash And Cash Equivalents End Of Year | 15.14 | 3.50 | 0.67 |